An evidence-based review of certolizumab pegol in the treatment of active psoriatic arthritis: place in therapy
María Laura Acosta-Felquer, Javier Rosa, Enrique R SorianoRheumatology Unit, Internal Medical Services, and University Institute, Hospital Italiano de Buenos Aires, Buenos Aires, ArgentinaAbstract: Certolizumab pegol (CZP) is a pegylated humanized tumor necrosis factor-α&nbs...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Dove Medical Press
2016
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/e03a92969113483db5c49e04601dd081 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|